Skip to content
Metaboliq
Menu

Thyroid and metabolism

The TSH reference range, and why yours might differ

TSH is the most ordered thyroid test in India and the most misread, partly because it moves in the opposite direction to intuition and partly because the range printed beside it is a statistical convention rather than a boundary in nature.

Not yet reviewed by a clinician

Nobody has signed this page off, so no name and no registration number are shown. We would rather say that than print one you cannot check. Every source below is named and linked in the meantime, so you can read them and disagree with us. The standard a reviewed page is held to is set out on our review standard page.

Published 15 August 2026 · Last updated 15 August 2026

Part of Thyroid and metabolism.

TSH is a message to the thyroid, not from it

Thyroid stimulating hormone is released by the pituitary gland, and its job is to instruct the thyroid to produce more hormone. When thyroid output falls, the pituitary raises TSH to push harder. When thyroid output is excessive, the pituitary backs off and TSH falls. So a high TSH generally indicates an underactive thyroid, which is precisely backwards from how most people read the word 'high' on a report.

That feedback arrangement is also why TSH is sensitive: it amplifies. A small fall in circulating thyroid hormone produces a proportionally larger rise in TSH, which makes it a good first test and a poor sole test, because the amplification also makes it responsive to things that have nothing to do with thyroid disease.

Sources: [3]

Where the printed range came from

The reference interval most laboratories print — commonly something close to 0.4 to 4.5 mIU/L — derives largely from large population surveys, of which the American NHANES III survey is the most cited. It is a description of where the middle 95 per cent of a reference population fell. It is not a description of where health ends and disease begins.

That same survey demonstrated something that complicates it further. When individuals with thyroid antibodies or a family history were excluded, the distribution of TSH in the remaining, more rigorously disease-free group shifted downward and narrowed. In other words, part of the upper end of the everyday reference range is occupied by people who have early thyroid disease, which is why a value near the top of the range is genuinely ambiguous rather than merely reassuring.

Sources: [1]

Whether the upper limit should be lowered as a result has been argued for two decades without resolution. Laboratories differ, assays differ, and a report from one is not strictly comparable with a report from another.

The range is not one range

TSH distributions shift upward with age, so a value that is unusual at twenty-five may be ordinary at seventy-five, and treating older adults against a young adult's interval risks acting on nothing. Pregnancy moves it in the other direction and has its own trimester-specific intervals, which is not a refinement but a different set of numbers entirely.

There is also within-person variation across a single day and across weeks. TSH has a diurnal rhythm, with values generally higher at night and in the early morning and lower in the afternoon. A morning sample and an afternoon sample from the same untreated person are not interchangeable, and neither is a sample taken during or shortly after an acute illness.

Sources: [2], [3]

Why one abnormal value is usually repeated

The consensus review that shaped modern practice on mildly abnormal thyroid results recommended confirming before acting, and that recommendation has held. A meaningful proportion of mildly raised values return to the reference interval when the test is repeated some weeks later, without anything having been done.

So the ordinary sequence after a mildly high TSH is a repeat after an interval, with free T4 measured alongside it and thyroid antibodies checked, rather than an immediate decision. The repeat is not a delaying tactic. It is the step that distinguishes a transient fluctuation from a trend.

Sources: [4], [2]

What is measured alongside it, and why

Free T4 establishes whether the thyroid's actual output has fallen or is still being maintained, which is the difference between overt and mild disease and changes the decision entirely. Anti-TPO antibodies indicate an autoimmune process, which changes the likelihood that a borderline value progresses and therefore changes the monitoring interval rather than the diagnosis.

This combination matters especially in India, where an eight-city survey reported a high prevalence of hypothyroidism and of antibody positivity, with a substantial share not previously detected. In a population with that background, a lone TSH with no antibody status attached leaves out the piece that determines what happens next.

Sources: [2], [5]

Reading the report you already have

Check three things before drawing any conclusion: the laboratory's own printed interval rather than one from the internet, whether free T4 was measured at all, and what time of day the sample was taken. Those three account for a large share of the confusion people arrive with.

Then take it to somebody who can read it against your age, your symptoms, any treatment you are already on and the rest of your metabolic panel. Thyroid results are not self-interpreting, and the specific failure mode here — a slightly high number, six months of worry, and no free T4 ever ordered — is entirely avoidable.

Sources: [2]

Where this comes from

Every source, in full

Linked to the publisher or to the abstract, so you can read them and disagree with us.

  1. [1] Hollowell JG, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)

    Journal of Clinical Endocrinology & Metabolism, 2002. The population survey from which the widely used TSH reference interval is derived, and the demonstration that the distribution shifts once people with thyroid antibodies are excluded.

    Read the source
  2. [2] Jonklaas J, et al. Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement

    Thyroid, 2014. The guideline covering when a raised TSH warrants treatment and when it warrants monitoring, the role of antibody status, and the modest size of weight change attributable to correction.

    Read the source
  3. [3] Chaker L, et al. Hypothyroidism

    The Lancet, 2017. A general review of hypothyroidism: how non-specific the symptom list is, how the diagnosis is made biochemically, and the natural history of untreated mild elevation.

    Read the source
  4. [4] Surks MI, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management

    JAMA, 2004. The consensus review that established retesting before acting on a single mildly abnormal thyroid result, and the limits of the evidence for treating the mild range.

    Read the source
  5. [5] Unnikrishnan AG, et al. Prevalence of hypothyroidism in adults: An epidemiological study in eight cities of India

    Indian Journal of Endocrinology and Metabolism, 2013. An eight-city Indian survey reporting a high prevalence of hypothyroidism and of anti-TPO positivity, with a substantial share not previously detected.

    Read the source

One next step

Health assessment

A TSH is interpretable only with free T4, antibody status and the rest of a metabolic panel beside it, read by a registered doctor.

₹1,799blood_panel_45_markers, home_collection, doctor_review, eligibility_decision, personalised_plan_day_3. Provided by Metaboliq with a partnered NABL-accredited laboratory.

Related reading

These answer the question next to this one

Because almost nobody arrives with exactly one question.